These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 17533020

  • 1. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G, Irish A, Chan D, Watts G.
    Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
    [Abstract] [Full Text] [Related]

  • 2. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK, Watts GF, Chan DC, Stanton K.
    Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
    [Abstract] [Full Text] [Related]

  • 3. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Taneva E, Borucki K, Wiens L, Makarova R, Schmidt-Lucke C, Luley C, Westphal S.
    Am J Cardiol; 2006 Apr 01; 97(7):1002-6. PubMed ID: 16563905
    [Abstract] [Full Text] [Related]

  • 4. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators.
    Am J Kidney Dis; 2009 May 01; 53(5):741-50. PubMed ID: 19216014
    [Abstract] [Full Text] [Related]

  • 5. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus.
    Amudha K, Choy AM, Mustafa MR, Lang CC.
    Cardiovasc Ther; 2008 May 01; 26(4):253-61. PubMed ID: 19035876
    [Abstract] [Full Text] [Related]

  • 6. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
    Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, Di Sciascio G, Covino E.
    Eur J Cardiothorac Surg; 2005 Dec 01; 28(6):805-10. PubMed ID: 16274999
    [Abstract] [Full Text] [Related]

  • 7. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E, Galicka-Latala D, Cieslik G, Rostoff P, Fedak D, Sieradzki J, Naskalski J, Piwowarska W.
    Diabetes Obes Metab; 2008 Sep 01; 10(9):719-25. PubMed ID: 17941871
    [Abstract] [Full Text] [Related]

  • 8. Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
    Chan DT, Watts GF, Irish AB, Dogra GK.
    Nephrol Dial Transplant; 2011 Nov 01; 26(11):3543-9. PubMed ID: 21378155
    [Abstract] [Full Text] [Related]

  • 9. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
    Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, TNT (Treating to New Targets) Investigators.
    J Am Coll Cardiol; 2008 Apr 15; 51(15):1448-54. PubMed ID: 18402899
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
    Vlachopoulos C, Aznaouridis K, Dagre A, Vasiliadou C, Masoura C, Stefanadi E, Skoumas J, Pitsavos C, Stefanadis C.
    Eur Heart J; 2007 Sep 15; 28(17):2102-9. PubMed ID: 17597050
    [Abstract] [Full Text] [Related]

  • 11. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV, Yegorova YV.
    Kardiol Pol; 2006 Jan 15; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [Abstract] [Full Text] [Related]

  • 12. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
    Diepeveen SH, Verhoeven GW, Van Der Palen J, Dikkeschei LD, Van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF.
    J Intern Med; 2005 May 15; 257(5):438-45. PubMed ID: 15836660
    [Abstract] [Full Text] [Related]

  • 13. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM, Unger P, Ghisdal L, Broeders N, Berkenboom G, Carpentier Y, Abramowicz D.
    Transplantation; 2006 Sep 27; 82(6):771-8. PubMed ID: 17006324
    [Abstract] [Full Text] [Related]

  • 14. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 27; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 15. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gómez-Campderá F, Vega A, Abad S, Luño J.
    J Am Soc Nephrol; 2006 Dec 27; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [Abstract] [Full Text] [Related]

  • 16. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
    Bauersachs J, Störk S, Kung M, Waller C, Fidler F, Hoyer C, Frantz S, Weidemann F, Ertl G, Angermann CE.
    Eur J Clin Invest; 2007 Nov 27; 37(11):852-9. PubMed ID: 17973781
    [Abstract] [Full Text] [Related]

  • 17. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH, CARDS Investigators.
    Am J Kidney Dis; 2009 Nov 27; 54(5):810-9. PubMed ID: 19540640
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep 27; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.